Product information and disease descriptionProduct descriptionProduct informationDrug/Drug, drug/disease interactions
Effects of Relutrigine on other drugs
1 evidence topic · 1 source
Relutrigine
SCN2A- and SCN8A-related developmental and epileptic encephalopathies
- Manufacturer
- Praxis Precision Medicines
- Regulatory submission
- NDA submitted in early 2026
- Launch
- Not announced
- Last updated